Showing results (91-100 of 241) with videos related to
Sort By:
Pageof 25
Dalton Transactions (Cambridge, England : 2003)|October 1, 2010
Antitumor activity of new hydridotris(pyrazolyl)borate ruthenium(II) complexes containing the phosphanes PTA and 1-CH3-PTAAlmudena García-Fernández, Josefina Díez, Angel Manteca, et al.European Journal of Medicinal Chemistry|July 13, 2010
Prenylflavonoids and prenyl/alkyl-phloroacetophenones: synthesis and antitumour biological evaluationP Basabe, M de Román, I S Marcos, et al.Journal of Leukocyte Biology|November 27, 2015
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activationSean C Patro, Livio Azzoni, Jocelin Joseph, et al.Archives of Medical Research|September 18, 1997
Quantification of bovine albumin fraction V in cellular antigens of antileptospirosical Cuban vaccine vaxSpiralT Valdés González, M González Pérez, M González González, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 11, 2019
III. THE ROLE OF THE RESEARCH ETHICS COMMITTEES IN THE REGULATION OF PHARMA-SPONSORED STUDIESCarlos A Aguilar-Salinas, Virginia Pascual-Ramos, Juan G Sierra-Madero, et al.FEMS Immunology and Medical Microbiology|September 11, 2001
Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistanceA Aguila, A G Herrera, D Morrison, et al.AIDS (London, England)|November 1, 1996
Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trialG Reyes-Terán, J G Sierra-Madero, V Martínez del Cerro, et al.Archives of Medical Research|January 1, 1994
Histopathologic and humoral study of Balb/c mice inoculated with BCG by different routesA Acosta, M E Sarmiento, A González, et al.HIV Clinical Trials|March 11, 2011
Maraviroc can improve lipid profiles in dyslipidemic patients with HIV: results from the MERIT trialA MacInnes, A Lazzarin, G Di Perri, et al.HIV Clinical Trials|March 18, 2015
The maraviroc expanded access program - safety and efficacy data from an open-label studyAdriano Lazzarin, Jacques Reynes, Jean-Michel Molina, et al.Pageof 25